Pharma Capital
Showing 40 of 57
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £81.17m £0.38 0.00% ico_glass.png
ahz[LOGO]200x100.jpg Admedus ASX £40.58m £0.16 3.77% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £16.09m £0.21 -5.62% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £10.01m £1.13 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £160.41m £0.27 0.00% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £251.85m £0.53 3.90% ico_glass.png
amryt-pharma.jpg Amryt Pharmaceuticals AIM £55.21m £0.27 -1.85% ico_glass.png
angle-logo.png ANGLE plc AIM £38.16m £0.51 0.99% ico_glass.png
avacta.png Avacta Group Plc AIM £66.00m £0.97 0.00% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £41.07m £0.90 0.00% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid ASX £16.15m £0.02 -3.70% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,011.73m £8.79 1.56% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £16.21m £0.05 2.56% ico_glass.png
concepta.png Concepta AIM £17.27m £0.16 0.80% ico_glass.png
Cynata.png Cynata Therapeutics ASX £29.73m £0.33 0.00% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £12.24m £0.04 13.79% ico_glass.png
Dimerix-logo-200.png Dimerix ASX £7.72m £0.00 -12.50% ico_glass.png
E--therapeutics-logo.png e-Therapeutics plc AIM £20.47m £0.08 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £83.43m £2.06 0.00% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £216.04m £7.78 0.65% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £67.55m £0.56 0.90% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £207.84m £2.16 -0.46% ico_glass.png
imm.gif ImmuPharma PLC AIM £72.06m £0.54 0.69% ico_glass.png
ixico-logo.png IXICO Plc AIM £8.68m £0.32 0.00% ico_glass.png
m_pharma_5739c0416b400.png M Pharmaceutical CSE £5.05m £0.02 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £138.47m £2.73 -1.80% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £52.84m £1.09 -0.46% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £63.66m £0.33 3.17% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £25.79m £0.51 0.00% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £12.88m £0.03 2.22% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £58.91m £0.75 -0.66% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals ASX £37.33m £0.37 -0.78% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis ASX £49.90m £0.16 0.00% ico_glass.png
pbi120.jpg Pressure Biosciences Inc OTCMKTS £- £- - ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £5.64m £0.10 -2.94% ico_glass.png
qbio.png Q BioMed Inc OTCMKTS £- £- - ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus ASX £15.12m £0.07 -10.71% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.